Compare ANL & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | PVL |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 57.8M |
| IPO Year | 2023 | N/A |
| Metric | ANL | PVL |
|---|---|---|
| Price | $1.04 | $1.88 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.8K | ★ 76.5K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 19.15% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $3,511,891.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.51 |
| Revenue Growth | N/A | ★ 11.77 |
| 52 Week Low | $0.88 | $1.30 |
| 52 Week High | $2.99 | $2.04 |
| Indicator | ANL | PVL |
|---|---|---|
| Relative Strength Index (RSI) | 37.72 | 57.21 |
| Support Level | $0.88 | $1.83 |
| Resistance Level | $1.59 | $1.90 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 33.93 | 81.25 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.